Intratympanically administered steroid for progressive sensorineural hearing loss in Ménière’s disease

Figures & data

Figure 1. Levels of hearing loss in the analysed population according to pure tone audiometry.

Table 1. Details of the audiometric results of patients from the ‘improved’ group.

	Age (years)	Gender (M: male, F: female)	Affected side (R: right, L: left)	Frequencies (Hz)	Mean improvement (dB)
1	70	F	R	All	18
2	68	M	R	All	20
3	44	F	L	500–1000	40
4	31	M	R	500–2000	20
5	68	F	L	All	30
6	73	F	R	All	15
7	65	M	L	500–1000	20
8	68	M	R	All	30
9	64	F	R	All	30
10	43	M	R	All	20
11	50	F	L	500–2000	15
12	54	F	L	500–2000	40
13	66	F	L	All	30

All means the whole frequency spectrum of audiometry (125, 250, 500, 1000, 2000, 4000 and 8000 Hz).

Figure 2. Analysis of effectiveness of steroids in the treatment of hearing loss.

Figure 3. Audiogram of the patient before the dexamethasone treatment: moderate hearing loss on all frequencies on the affected side (A: right side). Normal hearing on the unaffected side in EH (B: left side). O: air conduction, [: bone conduction (right), x: air conduction, >: bone conduction (left).

Figure 4. After intratympanic steroid treatment, a control audiometry was performed. The treatment was effective, because a 30 dB improvement in the hearing status was achieved.